ATHIRA PHARMA INC (ATHA) Stock Cash Flow
NASDAQ:ATHA - Nasdaq - US04746L1044 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -109.22M | -117.67M | -95.64M | -54.85M | -19.96M | |||
| Depreciation Amortization | 976.00K | 969.00K | 850.00K | 480.00K | N/A | |||
| Change In Working Capital | 283.00K | 6.53M | 11.94M | 6.16M | -6.45M | |||
| Other non cash items | 10.52M | 9.42M | 10.39M | 5.12M | 2.29M | |||
| OPERATING CASH FLOW | -97.45M | -100.75M | -72.47M | -43.10M | -24.11M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -37.00K | -304.00K | -1.14M | -1.57M | -2.32M | |||
| Other Investing Activity | 64.07M | 95.39M | 58.81M | -2.51M | -207.75M | |||
| INVESTING CASH FLOW | 64.03M | 95.09M | 57.66M | -4.08M | -210.07M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 1.66M | |||
| Stock Issued/Repurchased | 313.00K | 493.00K | 650.00K | 97.09M | 291.09M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 313.00K | 493.00K | 650.00K | 97.09M | 292.75M | |||
| CHANGE IN CASH | -33.11M | -5.17M | -14.16M | 49.91M | 58.57M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -97.45M | -100.75M | -72.47M | -43.10M | -24.11M | |||
| Capital Expenditure | -37.00K | -304.00K | -1.14M | -1.57M | -2.32M | |||
| FREE CASH FLOW | -97.49M | -101.06M | -73.61M | -44.67M | -26.43M | |||
All data in USD